The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs ...

The prescription drug legislation in the Inflation Reduction Act of 2022 — backed by AARP — directed the Department of Health and Human Services to work with pharmaceutical companies to secure reduced ...

The Centers for Medicare and Medicaid Services has confirmed the standard monthly premium will rise to $202.90 next year.

The Trump administration tapped a Biden-era rule to negotiate lower prices on 15 widely used medications for seniors.

The federal government’s newly announced savings on 15 expensive prescriptions include the popular Ozempic family of ...

The lower prices stem from the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The Trump administration said that had the new prices been in effect last year, Medicare would have saved $12 billion, which ...

In 2026, there are fewer prescription drug plans in Medicare Part D and higher premiums, even when offset by a ...

On Tuesday, the Trump administration celebrated drug price cuts it had secured through a Democrat-created program — despite Republicans’ longstanding antipathy of the policy.